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Oct4 is a maternally expressed octamer-binding protein
encoded by the murine Oct4 gene. It is present in un-
fertilized oocytes, but also in the inner cell mass and in
primordial germ cells. Here we show that the ectopic
expression of Oct-4 in HeLa cells is sufficient for
transcriptional activation from the octamer motif,
indicating that Oct4 is a transcription factor. Therefore,
Oct4 is the first transcription factor described that is
specific for the early stages of mouse development. The
spatial and temporal expression patterns were further
determined using in situ hybidization. With this technique
Oct4 expression is detected in the oocyte, in the blastocyst
and before gastrulation in the embryonic ectoderm. After
day 8 Oct4 expression decreases and is restricted to
primordial germ cells from about day 8.5 onwards.
Therefore Oct4 is a transcription factor that is
specifically expressed in cells participating in the genera-
tion of the germline lineage. Linkage analysis using B xD
recombinant inbred mouse strains demonstrates that
Oct4 maps to chromosome 17 in or near the major
histocompatibility complex. Several mouse mutants in the
distal region of the mouse t-complex affecting blastocyst




Muller-Immergluck et al., 1988; Tanaka et al., 1988; Thali
et al., 1988). In F9 cells the octamer mediates both transcrip-
tional activation (Scholer et al., 1989b) and repression
(Lenardo et al., 1989). In these cells, three octamer-binding
proteins are found in addition to the ubiquitously expressed
Oct-I protein (Scholer et al., 1989a). Oct4 and Oct-5 are
encoded by the Oct-4 gene (Scholer et al., 1990) whereas
the gene encoding Oct-6 remains to be isolated. Oct4 and
Oct-5 are also found in primordial germ cells, unfertilized
oocytes and in the inner cell mass (ICM) of blastocysts.
Therefore, Oct-4 and Oct-5 could control events in early
mouse embryogenesis.
We show that expression of Oct-4 cDNA was sufficient
to activate transcription from the octamer motif, indicating
that Oct-4 is a transcription factor. Also, the expression
pattern of the Oct-4 gene during embryogenesis was deter-
mined by in situ hybridization and the electrophoretic
mobility shift assay (EMSA). In preimplantation embryos,
Oct-4 expression was found in the blastocyst and before
gastrulation in the embryonic (primitive) ectoderm. Between
day 8 and 8.5 p.c., expression decreased dramatically and
was restricted at day 8.5 to the primordial germ cells which
were identified at the base of the allantois by histological
alkaline phosphatase staining (Stinnakre et al., 1981). The
primordial germ cells migrate from the base of the allantois
to the genital ridges (Chiquoine, 1954; Clark and Eddy,
1975) where they were easily detected both by their alkaline
phosphatase activity and their Oct-4 expression. Linkage
analysis using B xD recombinant inbred mouse strains
demonstrated that Oct-4 maps in or near the major histocom-
patibility complex (MHC). A cluster of t-lethal genes are
also associated with the MHC (Artzt, 1984), some of which
have profound effects on early mouse development. Cor-
relations between the Oct-4 expression pattern and the
phenotype of certain t-haplotypes lethals are discussed.
Introduction
Based on studies with Drosophila, current models of
development predict a hierarchy of regulatory genes guiding
the transformation of genetic information into embryonic
structure (for a review see Ingham, 1988). A number of
mouse genes identified by sequence similarity to Drosophila
genes may be involved in pattern formation (Holland and
Hogan, 1988; Kessel and Gruss, 1990). However, these
genes are expressed at later stages of mouse development.
Identification of regulatory proteins specific for early stages
of embryogenesis might help to unravel the predicted
developmental gene hierarchy of the mouse.
The octamer motif is a well-characterized cis-acting
element found in many promoters and enhancers (for a
review see Hatzopoulos et al., 1988). Octamer-binding
proteins from B or HeLa cells regulate transcription via the
octamer sequence motif (Dreyfus et al., 1987; Scheidereit
et al., 1987; Wirth et al., 1987; LeBowitz et al., 1988;
Oxford University Press
Results
Transcriptional activation by cloned Oct-4
Depending on its context relative to other motifs, the octamer
sequence confers transcriptional activation (Scholer et al.,
1989b) or repression (Lenardo et al., 1989) in F9 cells. In
addition to Oct-1, three octamer binding proteins are also
present in F9 cells that may modulate the activation or repres-
sion response of the octamer motif (Scholer et al., 1989a).
These include Oct-4 and Oct-5, which are differential trans-
lation products of the same gene (Figure la; Scholer et al.,
1990).
The Oct-4 cDNA was inserted in both orientations into
the eukaryotic CMV expression vector (Severne et al., 1988)
used previously to investigate transcriptional activation by
Oct-2A (Muller-Immergliick et al., 1988; Schreiber et al.,
1988; Thali et al., 1988). In this vector, transcription is under
the control of the human CMV enhancer/promoter combined
with a herpes simplex virus thymidine kinase (tk) leader
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Fig. 1. Vectors and probes used for the analysis of the Oct-4 gene. (a) Structure of the Oct-4 cDNA. The arrows indicate the start sites for Oct-4
and Oct-5, TGA the stop codon and AATAAA the polyadenylation hexamer. The thin line upstream of the Oct-4 start represents polylinker
sequences. Only restriction sites used for cloning and for generating probes are included. (b) shows the expression vectors and (c, d) the reporter
plasmids used in the trans-activation experiments. The sequence of the p6Wtk promoter region is outlined in Materials and methods (Figure 9).
(Figure lb). The coding sequence of Oct-2A in this vector
was replaced by that of Oct-4, utilizing the same tk leader
sequence and the same tk ATG. Due to the cloning pro-
cedure, the ATG of Oct-4 was deleted, resulting in a slightly
different Oct4 translation product in vitro and also in vivo
when ectopically expressed in HeLa cells. The size of Oct-5
remained unaffected (data not shown).
Two sets of target vectors were used in the trans-activation
experiments. First a set of target vectors was tested that
shows that the octamer motif is active in stem cells which
contain Oct-4 and Oct-5 (Scholer et al., 1989b). These
vectors (Figure lc) either contain six tandem repeats of a
mouse immunoglobulin heavy chain gene enhancer (IgH)
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minimal TK promoter. The distance between the TATA box
and the nearest octamer motif in these vectors is 147 bp.
The IgH fragments (1W) harbor the native (D) or mutated
(d) octamer motif and the ,xE4 site (F) (Church et al., 1985;
Ephrussi et al., 1985). In F9 stem cells the 6W enhancer
is at least 1000-fold more active than the mutated counter-
part (Scholer et al., 1989b).
The cDNA-containing expression vectors and the CAT
reporter plasmids were co-transfected in different combina-
tions into HeLa cells. Expression of Oct4 and Oct-2A was
confirmed by EMSA (data not shown). Reporter gene
expression was measured by the CAT assay and compared
with expression of a reference gene (,B-actin- lacZ) (Figure
2). Surprisingly, trans-activation was not observed with the
Oct4 (lanes 6 and 7) or Oct-2A (lanes 1 and 2) expression
vectors. Although the CAT activities of p6WtkCAT and
pFdtkCAT are higher than ptkCAT (lanes 5 and 10), no
difference was observed between 6W and 6Fd, indicating
that no trans-activation was occurring via the octamer motif.
Activation above ptkCAT control is likely to be due to the
14E4 motif, because similar results were obtained after
transfection without trans-activator (Scholer et al., 1989b).
A second set of target vectors (Figure ld), in which a
single IgH octamer (pD3CAT) or its mutated counterpart
(pd,BCAT) is close to the rabbit j3-globin TATA box, was
tested in trans-activation assays. This particular arrangement
ofTATA box and octamer motif is trans-activated by Oct-2A
(Muller-Immergluck et al., 1988, 1990). Reporter gene
expression was measured by the CAT assay and compared
with lacZ expression. In the absence of a functional trans-
activator, reporter gene expression was not detectable (Figure
2, lanes 11 and 12), whereas co-transfection of functional
Oct-4 or Oct-2A significantly induced reporter gene expres-
sion via the octamer motif (lanes 3, 4 and 8, 9). Trans-
activation by Oct-4 was about twice as high as by Oct-2A
(lanes 3 and 8), although about ten times more radiolabeled
1W was shifted by Oct-2A than by Oct-4 in the EMSA (not
shown).
Expression of the Oct-4 gene in oocytes and the
preimplantation embryo
Oct-4 is detectable in extracts of unfertilized oocytes (Scholer
et al., 1989a), blastocysts (Figure 3) and in two cell lines
derived from the mouse ICM, D3 (Scholer et al., 1989a)
and tI1Il (not shown) (Winking and Guenet, 1978). An
Oct-4-like protein is also found in the human embryonal car-
cinoma line NT2 (not shown), a subclone of the Tera-2 cell
line (Fogh, 1978). With the standard procedure (see
Materials and methods) this complex has a slightly lower
mobility than the F9 Oct-4 complex (not shown). The
presence of Oct4 correlates with transcriptional activity via
the octamer motif in cells derived from the ICM (Scholer
et al., 1989b). In blastocysts, lacZ expression mediated by
the octamer is only in the ICM (Scholer et al., 1989b).
The distribution of Oct-4 transcripts in the ovary and
during early mouse embryogenesis was determined by in situ
hybridization using 35S-labelled probes. Sense and anti-
sense RNA probes were transcribed from linearized plasmids
containing a 462 bp Oct-4 cDNA insert (Figure la;
fragment C).
To investigate Oct-4 transcription at the preimplantation
stage, blastocysts were recovered from the oviduct and
uterus, transferred into oviducts and treated as described by
F- I F. -.
Fig. 2. Promoter activation by cloned Oct-4. The expression vectors
[CMV-Oct2(+); CMV-Oct4(+); CMV-Oct4(-)] and reporter plasmids
(6W: p6WtkCAT; 6Fd: p6FdtkCAT; D: pDI3CAT; d: pd,BCAT; tk:
ptkCAT) were cotransfected with ,B-actin-lacZ into HeLa cells as
indicated. The expression vectors and reporter plasmids are outlined in
Figure 1.
Lyons et al. (1989) and Graham et al. (1989). With this pro-
cedure, high levels of Oct-4 transcripts were detectable in
the blastocyst (Figure 3b-d). In the early (b) and in the
expanding blastocyst (c) Oct-4 is expressed uniformly.
Thereafter, expression decreases significantly in the
trophoblast, and increases in the ICM (d). No signal is detect-
able in cells of the oviduct (Figure 3e) or with sense RNA
(not shown).
Oct-4 expression is also found in oocytes, where it is
readily detectable in a bright-field image of the ovary (Figure
3f). The signal intensity in the blastocyst is much higher
than in the oocyte, probably due to higher expression of
Oct-4 in the blastocyst (Figure 3g).
Expression of the Oct-4 gene in the postimplantation
embryo
At the egg cylinder stage, Oct 4 transcripts can be easily
detected in the embryonic ectoderm. Figure 4a, b shows a
mid-frontal section through a 7 day embryo where the
ectodermal and endodermal germ layers can be easily
discerned. High levels of Oct-4 transcripts are visible in the
ectoderm, but no transcripts above background are detect-
able in endoderm, trophoblast, allantois and other extra-
embryonic tissues. At this stage, mesoderm is formed by
ingression through the primitive streak. In a rear-frontal
section of a 7 day embryo (Figure 4c) and a cross section
through a 7.5 day embryo (Figure 4d), it is apparent that
mesoderm does not express Oct-4 at the high levels found
in ectoderm. Ectodermal expression can already be detected
by day 6 in embryonic ectoderm (data not shown).
By day 8.0 ingression through the primitive streak is
almost complete and the neural tube begins to take shape.
Oct-4 continues to be expressed in neural ectoderm at high
levels, as shown in Figure Sa, b. (Note that the head fold
is evident although no somites are discernible in this par-
ticular embryo). Approximately 12 h later, when
somitogenesis has begun, the levels of Oct-4 transcripts start
to decrease. Figure Sc, d shows an 8.5 day embryo with
a well developed headfold and foregut pocket. This is a
skewed sagittal section through the neural tube which has
not yet closed. This embryo has 5-6 visible somites,
although only those adjacent to the neural tube cross-section
are visible in this section. The level of expression as
estimated from the dark field picture is clearly less than at
























Fig. 3. Expression of Oct-4 in mouse oocytes and blastocysts. (a) Presence of Oct-4 in mouse blastocysts. Radiolabelled 1W was incubated with
whole cell extracts of undifferentiated F9 cells (lane 1) and blastocysts (lane 2). The shift corresponds to an extract of ten day 3.5 blastocysts. (b to
d): In situ hybridization of Oct-4 anti-sense RNA to an early (b), an expanding (c) and a late blastocyst (d), showing a restriction of Oct-4
expression to the ICM during blastocyst development. The late blastocyst has probably 'hatched' from the zona pellucida, as indicated by the
elongated body and the flattened trophoblastic cells. (e-g): In situ hybridization to sections of an oviduct (e, g) and an ovary (f) showing that an
Oct-4 signal is detectable only in oocytes and blastocysts. (f) shows Oct-4 expression in a small, a medium and a large follicle. At the lower left
corner a type 3b (or 4), right next to it a type 1 (or 2) and at the higher right corner a type 5b follicle is identified according to Pedersen and Peters
(1968). One oocyte is not attached to follicle cells in (f), due to shrinkage of the oocyte and the zona pellucida during fixation. This is probably also
seen in (g), where follicle cells are found around the oocyte. The hybridization signal is higher in blastocysts than in oocytes as shown in (g). b-g
are bright-field images of oviduct and ovary sections.
c
neural folds is lower than at the posterior end of the neural
tube. The primordial germ cells, located at the posterior end
of the embryo where the allantois, the amniotic membrane
and the three germ layers of the embryo converge
(Chiquoine, 1954; Clark and Eddy, 1975), also express high
levels of Oct-4. Figure 6a shows a section of a day 8.5
embryo and Figure 6b an enlarged section. Both are stained
for alkaline phosphatase activity, a convenient marker for
primordial germ cells. A similar section of another embryo
shows several clusters of cells in the expected position of
the primordial germ cells expressing high levels of Oct-4
(Figure 6c). After day 8.5, expression continues to decrease
to undetectable levels in ectoderm derived tissues, whereas
the primordial germ cells continue to express Oct-4.
Migration of the primordial germ cells through the
mesenteries to their final place in the developing gonads is
complete by day 11. At this stage, germ cells can be
identified in the genital ridge by alkaline phosphatase stain-
ing, and Oct-4 transcripts can still be easily detected (Figure
Se, f). No other tissue exhibits detectable levels of Oct-4
transcripts, including all neural tissue derived from the
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approximately day 8.5 in the neural tube and expression
becomes restricted to germ cells thereafter. In accordance
with the decrease of Oct-4 RNA, Oct-4 protein detected with
EMSA decreases significantly between day 8.5 and 9.5
whereas the amount of Oct-I1protein detected increases
(Figure 7). To normalize comparisons of different
developmental stages in EMSA, poly d(I C) was omitted
and equal amounts of protein were used in each lane.
Omission of poly d(I - C) resulted in additional nonspecific
complexes which were found in every developmental stage
and tissue tested, and could be destroyed by poly d(I - C)
competition (not shown).
Genetic mapping of the Qct-4 gene
The map position of the Oct-4 gene was determined by
recombinant inbred (RI) strain analysis (Taylor, 1978; Lyon
and Searle, 1989). A RFLP between the C57BL/6J (B) and
DBA/2J (D) strains of mice was identified using a 350 bp
fragment spanning the 5' region of the Oct-4 cDNA (frag-
ment B; Figure lA). The strain distribution pattern of the
B and D alleles of the Oct-4 locus was then determined by
hybridization of the Oct-4 probe to Southern blots of genom-ic
DNA of 26 strains in the B X D RI set. The strain distribu-
tion pattern is shown (Table I) in comparison with those
determined for other markers mapping to the MHC com-
plex. No recombination was detected between Oct-4 and Tla
or H2-S in 26 RI strains, therefore the map position of Oct-4
is likely to be within 0+4.2 cM from the H2-S or Tla (95%
confidence; calculation according to Silver, 1985).
The Oct-4 locus separated from both the a A-crystallin
gene (Crya-J) and Ms15-3 in one strain of the B xD RI set;
Oct-4 therefore maps between Crya-J and MsJ5-3 (Table I;
Vincek et al., 1989). The estimated map distance ofMs15-3
and H-2 is 1.1 cM and thus Ms15-3 has been placed bet-
ween H-2 and Tla (Jeffreys et al., 1987; Lyon and Searle,
1989). This would mean that Oct-4 is within the MHC.
However, as the markers Dl7Leh89 and D17Leh525 also
show no recombination with Oct-4 in the B xD series and
have been reported to map distally to Tia (Bucan et al.,
1987), it cannot be excluded that Oct-4 and MslS-3 map
distally to the MHC complex (Silver, 1985).
The identical strain distribution patterns for the Oct-4 locus
and for sequences in the Tla and H2-S region indicate that
Oct-4 maps at least near to the MHC complex. As a first
attempt to see if Oct-4 is within the MHC, we examined
whether Oct-4 sequences could be detected in any of the
cosmids that span large parts of the H2-S, H2-D, H2-Qa
and H2-Tla regions (Steinmetz et al., 1982, 1984; Fischer
et al., 1985; Stephen et al., 1986; Muller et al., 1987).
However, using the Oct-4 cDNA clone as a probe (fragment
A in Figure la), no positive signal was obtained.
Discussion
Oct-4 acts as a transcription factor
Oct-4 expression in HeLa cells was driven by the human
CMV enhancer, which is very strong in these cells. Trans-
activation by Oct-4 was studied with two sets of target vec-
tors and the results were compared with those obtained with
the Oct-2A transcription factor. The 6W enhancer, a potent
enhancer in F9 cells, was not activated by Oct-4 or Oct-2A
in HeLa cells. However, a weak promoter consisting only
of an octamer next to the TATA box was readily activated
in HeLa cells. Several explanations might account for this
discrepancy. First, the distances between the TATA boxes
and the octamer are different. In the case of p6WtkCAT,
the distance is 147 bp, whereas in pD3CAT both motifs are
separated by only 20 bp. In p6WtkCAT, two GC boxes and
one CAAT box are located between the octamer and the
TATA box (Figure 9). However, the influence of the GC
and CAAT boxes on transcriptional activation in p6WtkCAT
remains to be determined. A distance effect between the
octamer and TATA box has been described for B-cells
(Wirth et al., 1987). When the octamer motif is within 40
bp upstream of the [B-globin TATA, it is sufficient for direct-
ing lymphocyte-specific RNA synthesis. However, moving
the octamer - 220 bp upstream of the TATA box did not
induce transcription. Even with the ectopic expression of
Oct-4 or Oct-2A, the octamer motif might act as a proximal
promoter element in HeLa cells. Similar results were also
obtained by other groups (Muller-Immergluck et al., 1988,
1990; Tanaka and Herr, 1990). In their experiments
co-transfected Oct-2A was only able to act on a nearby
TATA and not from a position far upstream or downstream.
In BJA-B cells, which contain abundant Oct-2A, even the
downstream position was suitable for the stimulation of
transcription (Gerster et al., 1987).







Fig. 5. Expression of Oct-4 in 8-day embryos and in primordial germ cells of an 11-day embryo. In situ hybridization to a sagittal section of a day
8 (a, b) and to a skewed sagittal section of a day 8.5 (c, d) embryo. (b) and (d) are dark-field images of (a) and (c), respectively. The headfold of
each embryo is left, the allantois is right. (e) shows a bright-field image of a genital ridge (sagittal section of an 11-day embryo) stained for alkaline
phosphatase activity. (f) is a dark-field image of a serial section of the genital ridge hybridized for Oct-4 expression.
proteins are present in these cells that are missing from
HeLa. One putative site of interaction with such protein(s)
is the hinge region between the first and second POU
homeodomain helix of Oct-4 (Scholer et al., 1990). Alter-
natively, additional factors might be present in HeLa cells
that do not allow Oct-4 to activate transcription from a
distance. A third explanation is that binding of Oct-4 to
(almost) all octamer sites is necessary for 6W to act as an
enhancer. If not enough Oct-4 is present in the trans-
activation experiments, only a few sites would be occupied
by Oct-4 and the enhancer would be silent. Alternatively,
the Oct4/Oct-l ratio could be important, because too much
Oct-I binding to 6W might neutralize the effect of bound
Oct-4. pDfCAT contains only one octamer motif in front
of the TATA box, therefore every bound Oct-4 activates
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Fig. 6. Day 8.5 expression of Oct-4 in primordial germ cells. In (a) a
sagittal section of a day 8.5 embryo is stained for alkaline phosphatase
activity to show primordial germ cells at the base of the allantois. (b)
and (c) are sections to compare alkaline phosphatase activity (b) and
Oct-4 expression (c) at the cell level.
Oct-factors were not limiting. When different amounts of
p6WtkCAT were transfected into F9 cells, adding carrier
DNA to yield the same total amount of DNA, the 6W
enhancer activity increased linearly (Scholer et al., 1989b).
Finally, Oct-4 may act preferentially as a promoter transcrip-
tion factor and Oct-6, which in addition to Oct-4 is also found
in F9 cells, could be responsible for enhancer activation.
In a recent publication, Okamoto et al. (1990) described
Fig. 7. Specific decrease of Oct-4 complexes during early mouse
development. Radiolabelled 1W was incubated with whole cell extracts
of day 7.5 (lane 1) day 8.5 (lane 2) and day 9.5 (lane 3) embryos.
The shifts correspond to extracts of less than one-quarter of an embryo
each. Poly d(I-C) was omitted in this experiment to utilize additional
DNA binding proteins as an internal standard. The positions of Oct-4
and Oct-5 were determined by comparison with a F9 extract (not
shown).
cDNA cloning of an octamer-binding protein (Oct-3) from
a P19 library. We think that the Oct-3 protein is also encoded
by the Oct-4 gene because the nucleotide sequences of the
Oct-4 and Oct-3 cDNAs are identical except for two
differences (Scholer et al., 1990). The identity of Oct-4 and
Oct-3 is also indicated by Southern blot analysis with
restriction-digested mouse DNA (data not shown).
In the functional analysis of the Oct-3 protein, Okamoto
et al. (1990) used a target vector that had six tandem repeats
of the octamer in front of the SV40 early promoter. Although
this vector is active in P19 cells, trans-activation by Oct-3
in differentiated cells could not be demonstrated. This is
similar to the results discussed above. To demonstrate that
the Oct-3 cDNA encodes a transcription factor they used
an indirect approach. When Oct-3 anti-sense RNA was
expressed in P19 cells, the activity of the target decreased
significantly, indicating that Oct-3 takes part in transcrip-
tional activation.
Oct-4 is a transcrption factor specifically expressed in
the germline
The regulation of Oct-4 expression during early
embryogenesis is a dynamic, multi-step process (Figure 8).
Both male and female primordial germ cells express Oct-4
as determined by EMSA (Scholer et al., 1989a) and in situ
hybridization to mRNA. However, unfertilized oocytes con-
tain Oct-4 protein whereas sperm does not. Upon fertiliza-
tion, maternal Oct4 would be the only Oct4 source in the
zygote until zygotic gene transcription is activated. The stage
at which Oct-4 is first transcribed in the zygote is unclear.
However, Oct-4 is actively transcribed in the preimplanta-
tion embryo and expression increases and continues only in
the ICM during blastocyst development. Interestingly, the
6W enhancer is active in ICM and not in the trophectoderm
of transgenic blastocysts (Scholer et al., 1989b). The activity
of the octamer in the ICM matches with its activity in the
embryonal stem cell line D3, itself derived from the ICM
of blastocysts. Moreover, the D3 cell line contains Oct-4
protein, as does the embryonal carcinoma cell line F9. In
both cases the activity of the octamer motif correlates with
the presence of Oct-4. Although a restriction of Oct-4









Table 1. Recombinant inbred strain (B x D) segregation pattern of the Oct-4 gene
Locus B x D
1 2 5 6 8 9 11 12 13 14 15 16 18 19 20 21 22 23 24 25 27 28 29 30 31 32
Crya-J D B D D B D D D B B B D D B B D D B D D B D B D D D
x
H2-S D B D D B D D D B B B D D B B D D B D D D D B D D D
T7a
DJ7Leh89 D B D D B D D D B B B D D B B D D B D D D D B D D D
DI 7Leh525
Oct-4 D B D D B D D D B B B D D B B D D B D D D D B D D D
x
Msl5-3 D B D D B D D B B B B D D B B D D B D D D D B D D D
ment, the question remains why the octamer motif is not
active in trophoblast cells. The same reasons as outlined
which lead to the lack of trans-activation of the 6W enhancer
in HeLa cells might also account for the lack of activity in
the trophoblast (see above). In addition, although Oct-4
transcripts are readily detectable in the trophoblast, it remains
unclear whether they lead to an active translation product.
It also remains unclear why Oct-4 is expressed in
embryonic ectoderm and neural ectoderm. Prior to day 7,
cells of the embryonic ectoderm have some degree of
pluripotency and can give rise to many different cell types
in teratocarcinomas (Evans and Kaufman, 1983). Studies
addressing the potency of embryonic ectoderm (Beddington,
1981, 1982; Snow, 1981; Snow and Monk, 1983) indicate
that distal ectoderm just posterior to the primitive streak from
7 day embryos can contribute to a variety of structures
including somites, mesoderm, gut endoderm and notochord.
Anterior ectoderm is more restricted in developmental
potency and contributes primarily to head surface ectoderm
and head neural ectoderm. The regional specification of the
7 day embryo is described in detail by Snow (1981) and Tam
(1989) and appears to precede cell-type restriction, as there
is little cell mixing along the anterior-posterior axis. The
potency of ectodermal cells becomes more and more
restricted beginning at approximately day 7. Although the
three primary germ cell layers are all derived from the
embryonic ectoderm, only the neural ectoderm still expresses
Oct-4 at day 8. Thus, as cells of the ectoderm ingress through
the primitive streak and form mesoderm, Oct-4 expression
is shut off. Similarly, as the developmental potency of
ectoderm cells in the neural plate becomes more restricted,
Oct-4 expression is turned off. Only the primordial germ
cells, also derived from ectoderm (Snow, 1981; Tam, 1989),
continue to express Oct-4; their developmental potency is
unlimited, once differentiated and fertilized. In summary,
Oct4 may be required to maintain potency in the cells of
the early embryo.
Oct-4 maps in or near the major histocompatibility
complex
The chromosomal location of the Oct-4 gene was determined
by recombinant inbred strain analysis (Taylor, 1978). The
same strain distribution pattern for Oct-4, Tla and H2-S was
found, indicating that Oct-4 maps on chromosome 17 in or
near the MHC complex (Lyon and Searle, 1989). The MHC
complex is located at the distal region of the t-complex, for
which several dominant and recessive mutations are known
(for a review see Frischauf, 1985).
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Fig. 8. Germline specific expression of the Oct-4 gene. Boxes: cells
and tissues representing the germline; hatched boxes and circles: cells
and tissues expressing Oct-4; in tissues and cells that are not framed,
expression of Oct-4 is not detectable or strongly reduced; expression
of Oct-4 was not investigated in the zygote and in the morula.
Several of the t-haplotype lethal alleles mapping to the
MHC complex have profound effects on early mouse
development. One complementation group is characterized
by the failure of blastocyst formation on day 3 of develop-
ment (tJ2 and tW32), a second shows defects in the forma-
tion of embryonic ectoderm (to and t6) and a third leads to
death of embryonic ectoderm (tw5) (Magnuson, 1983 and
ref. therein). t° and t6 belong to a cluster of t-lethal alleles
mapping close to tufted (tf) and therefore are too far away
to be due to a mutation of the Oct-4 locus. However, the
other two groups belong to a cluster of t-lethal alleles
associated with the MHC locus (Artzt, 1984; Shin et al.,
1984).
Because Oct-4 is expressed during preimplantation
development, t-lethal mutant phenotypes, which fail to form
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Fig. 9. Sequence of the 6Wtk promoter region. Construction of p6WtkCAT as described by Scholer et al. (1989b). The octamer motif, the TATA,
GC and CAAT boxes are indicated above the sequence.
blastocysts, may be the result of a mutation or a deletion
in the Oct-4 gene. t12 and t32 result in preimplantation
lethality when homozygous. t12 homozygous embryos arrest
in development at the late morula stage ( - 32 cells ) (Smith,
1956) whereas those homozygous for tw32 arrest in develop-
ment at the early morula stage (- 16 cells) (Hillman et al.,
1970). t12/tw32 heterozygotes also die at the early morula
stage (Hillman, 1975).
The death of the embryonic ectoderm of tw5 homozygotes
at day 7-8 correlates with the high levels of Oct-4 expres-
sion at this time. Some tw5 embryos develop to 10 days
although they become completely extraembryonic and con-
sist of only yolk sac, chorion and allantois (Bennett and
Dunn, 1958).
itub' (Winking and Guenet, 1978) is another allele belong-
ing to the cluster of t-lethals associated with the MHC (Artzt,
1984). However, extracts from an embryonal stem cell line
homozygous for &lUlJ gave a strong Oct-4 complex in
EMSA, indicating that synthesis of Oct-4 occurs and binding
is not affected (data not shown).
Oct4 is present in primordial germ cells, unfertilized
oocytes and in the mouse blastocyst. Therefore this transcrip-
tion factor could be regulating very early developmental pro-
cesses, acting prior to other putative control genes, such as
Hox or Pax genes. It will be interesting to determine whether
Oct-4 regulates members of other gene families (Dressler
and Gruss, 1988). The dramatic down-regulation of Oct-4
expression after day 8 might be necessary for the differentia-
tion of the embryonic ectoderm into different tissues.
Although we have demonstrated that Oct-4 can act as a
transcription factor, it might also repress transcription when
the octamer motif is in a different context (Lenardo et al.,
1989). A more detailed mapping of the Oct-4 gene in rela-
tion to any of the t-mutants might allow a functional analysis.
Taken together, we think that Oct-4 is a good candidate for
a gene involved in control events of early mouse
development.
Materials and methods
Cell lines and transfection
HeLa cells were grown and transfected as described elsewhere (Scholer
and Gruss, 1984; Scholer et al., 1989b). HeLa cells were transfected with
15 yg reporter plasmid, 5 Ag expression vectors and 5 jig (3-actin-LacZ.
After harvesting, one-tenth of the cells were used for the microextraction
procedure.
Recombinant plasmids and oligonucleotides
ptkCAT, p6WtkCAT, p6FdtkCAT and the Oct-4 cDNA clone have been
described previously (Scholer et al., 1989b and 1990). The sequence of
the 6Wtk promoter is shown in Figure 9. CMV-Oct2A(+) has been described
by Muller-Immergluck et al. (1988). The Oct-2A cDNA in CMV-Oct2A(+)
was replaced by Oct-4 cDNA (Figure la; fragment A) in either sense or
anti-sense orientation by standard recombinant procedures. Both SnaI restric-
tion sites of CMV-Oct2A(+) were used for the replacement (E.Schreiber,
personal communication). pD(3CAT and pdi3CAT were constructed by
replacing the XbaI-XhoI fragment of ptkCAT (including the tk promoter)
with the synthetic oligonucleotides indicated in Figure Id. (3-actin-lacZ
is a plasmid containing the lacZ gene driven by the human (3-actin pro-
moter (A.Puschel, unpublished data). The 1W oligonucleotide has been
described previously (Scholer et al., 1989a).
CAT and ,8-galactosidase assays
CAT assays were performed as described elsewhere (Scholer and Gruss,
1984) with the following modifications: 150 td of a total of 180 Il were
incubated for 3 h and 4 mM acetyl-CoA was added after 60 and 120 min.
Autoradiography was performed for 72 h. (-galactosidase assays were per-
formed as described in Sambrook et al. (1989).
Isolation of blastocysts and day 7.5 - 9.5 p.c. embryos
Day 3.5 (blastocysts), 7.5, 8.5 and 9.5 embryos were isolated as described
by Hogan et al. (1986). Decidual tissue (day 7.5) and visceral yolk sac
(day 8.5 and 9.5) were discarded and the embryos frozen immediately in
liquid nitrogen.
Microextraction procedure for the preparation of whole cell
extracts and the electrophoretic mobility shift assay (EMSA)
The microextraction procedure and the EMSA were performed as described
previously (Scholer et al., 1989a) except for using 100 mM NaCl in the
extraction buffer.
DNA isolation and analysis
Total cellular DNA from C57BL/6J and DBA/2J mice was isolated by
standard techniques. B x D RI strain DNA was purchased from the Jackson
Laboratory (Bar Harbor, Maine). Genomic DNA was digested, separated
by electrophoresis and blotted onto GeneScreen Plus membrane by alkaline
transfer. The filters were baked at 80'C for 30 min and hybridized over-
night at 42°C in 50% formamide, 1% SDS, 1 M NaCl with the Oct-4 probe
(Figure la; fragment B). The filters were washed twice at room temperature
for 30 min in 2 x SSC, twice at 65°C for 30 min in 2 x SSC, 1% SDS
and finally twice in 0.1 x SSC at 650C for 30 min.
In situ hybridization (Figures 4, 5, 6)
The techniques employed for in situ hybridization were essentially those
of Hogan et al. (1986) with modifications by Dony and Gruss (1987). Day
6, 7, 8 and 9 embryos were dissected out of the uterus but left in the decidua
for sectioning. Day 11 embryos were dissected free of extra-embryonic
tissues prior to sectioning. 8 ltm sections were cut at -200C, dried for
10-15 min at 55'C and fixed in 4% paraformaldehyde. Sections were
pretreated in 2 x SSC at 70°C for 30 min and digested with 0.1 mg/ml
pronase for 10 min at room temperature. After rinsing in PBS, sections




A 462 bp Oct-4 cDNA fragment (fragment C in Figure la) was cloned
into Bluescript (Stratagene) and linearized with an appropriate restriction
endonuclease. The highest homology of this probe to a known DNA sequence
is < 70% (tst-1; N.Suzuki and H.R.Scholer, unpublished results). RNA
probes were transcribed using T3 and T7 polymerases according to the
manufacturer's instructions (Promega). Labelled RNAs were precipitated
with 10% TCA and collected on nitrocellulose filters. Probes were eluted
from the filters in 50 mM EDTA, 0.1% SDS at 65°C for 30 min and
subjected to limited alkaline hydrolysis to achieve an optimum probe length
of 100-200 nucleotides. Probes were diluted to 5 x 104 c.p.m./Al in
hybridization buffer containing 50% formamide, 10% dextran sulphate, 0.3
M NaCl, 10 mM Tris, 10 mM NaPO4 pH 6.8, 5 mM EDTA, 10 mM
DTT, 1 x Denhardt's, and 10 AM [35S]ATP. Approximately 6-10 iLl of
hybridization mix was used per section, depending on the size of the
coverslip. Hybridization was performed overnight at 420C in a humid
chamber. Slides were washed at 500C in 2 x SSC, 50% formamide at 370C
until coverslips floated free. Slides were digested with 20 ig/mli of pan-
creatic RNase (Ingham et al., 1985) and washed overnight at 37°C in 50%
formamide, 2 x SSC. Slides were dipped in Kodak NTB2 emulsion and
exposed for 7 days. Slides were developed and stained with thionin.
Alkaline phosphatase activity was detected ujsing the method of Stinnakre
et al. (1981). The sections were fixed as for in situ hybridization and
dehydrated. Sections were incubated for 10 min in 75 mM Tris pH 8.6,
0.8% NaCI, 2% dimethylformamide, 0.05% sodium napthol ASMX
phosphate and 0.1 % fast red TR. Sections were rinsed in water briefly and
counterstained for 1 min in neutral red.
In situ hybridization (Figure 3)
The techniques employed for in situ hybridization of blastocysts were those
of Hogan et al. (1989) and Graham et al. (1989). Blastocysts were recovered
from the oviduct and uterus (Hogan et al., 1989) and transferred into
oviducts. Subsequently, the oviduct was dissected, fixed in 4% paraform-
aldehyde for 16 h at 4°C and embedded in paraffin wax. 6 Am sections
were cut and dried for 60 min at 37°C. The sections were dewaxed in xylene,
refixed in 4% paraformaldehyde, digested with 0.02 mg/mi proteinase K
and treated with acetic anhydride. After dehydration the sections were
hybridized with the probe (see above) for 16 h at 500C in a hybridization
buffer containing 50% formamide, 10% dextran sulphate, 100 mM DTT,
0.3 M NaCI, 110 mM Tris, 5 mM EDTA, 10 mM sodium phosphate, 2%
BSA, 2% polyvinylpyrrolidone, 2% Ficoll type 400. Slides were washed
at 370C in 2% SSC, 50% formamide, 1 mM DTT for 4 h and subsequently
treated with 20 Atg/ml RNase A at 370C for 15 min. Washing was con-
tinued for 16 h at 370C in 2% SSC, 50% formamide, 1 mM DTT, then
slides were dehydrated and air dried. Slides were dipped in Kodak NTB2
emulsion, exposed for 10 days, developed and stained with Giemsa.
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Note added in proof
The symbol Oct-4 has been accepted by the Committee on 'Standardized
Genetic Nomenclature for Mice' and will be published together with the
mapping in the July issue of Mouse News Letter.
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